Table 2 List of clinical trials included in the ORR analysis

CA209-067

n + i = 314

n = 316

n + i = 58.3%

n = 44.6%

CA209-227

n + i = 396

n = 396

n + i = 35.9%

n = 27.5%

IFCT-1501 MAPS2

n + i = 54

n = 54

n + i = 27.8%

n = 18.5%

Alliance A091401

n + i = 38

n = 38

n + i = 15.8%

n = 5.3%

CA209-032 (GastricCancer)

n + i = 49*

n + i = 52**

n = 59

n + i = 24.5%

n + i = 7.7%

n = 11.9%

CA209-032 (BladderCancer)

n + i = 196

n = 78

n + i = 34%

n = 24%

CA209-032 (SCLC)

n + i = 147

n = 95

n + i = 21%

n = 12%